![Bruce Vielle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Bruce Vielle currently works at Le Groupe Synerlab SAS, as Chairman & Chief Executive Officer, Meribel Pharma Financière France SAS, as Chief Executive Officer from 2019, Famar SA, as Chief Executive Officer from 2026, and Pharmaster + SAS, as Chairman from 2019.
Postes actifs de Bruce Vielle
| Sociétés | Poste | Début |
|---|---|---|
Le Groupe Synerlab SAS
 Le Groupe Synerlab SAS Pharmaceuticals: MajorHealth Technology Engages in manufacturing and development of multiple dosage forms | Directeur Général | - |
Pharmaster + SAS
 Pharmaster + SAS Pharmaceuticals: MajorHealth Technology Manufactures sterile liquid products, ophthalmic, ear and nasal devices | Président | 25/05/2019 |
Financière SynerLAB SAS
 Financière SynerLAB SAS Pharmaceuticals: MajorHealth Technology Engages in development and production of pharmaceuticals | Directeur Général | 01/01/2019 |
Famar SA
 Famar SA Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization servicing the pharmaceutical industry | Directeur Général | 03/08/2026 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Famar SA
Famar SA Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization servicing the pharmaceutical industry | Health Technology |
Financière SynerLAB SAS
Financière SynerLAB SAS Pharmaceuticals: MajorHealth Technology Engages in development and production of pharmaceuticals | Health Technology |
Pharmaster + SAS
Pharmaster + SAS Pharmaceuticals: MajorHealth Technology Manufactures sterile liquid products, ophthalmic, ear and nasal devices | Health Technology |
Le Groupe Synerlab SAS
Le Groupe Synerlab SAS Pharmaceuticals: MajorHealth Technology Engages in manufacturing and development of multiple dosage forms | Health Technology |
